|
|
||||||||
Division of Cellular Immunology, National Institute for Medical Research, London, United Kingdom
The interaction of CD40 on B cells with the CD40 ligand (CD40L) on preactivated CD4 T cells is critical for the initiation of T-dependent Ab responses. It is believed that signals via CD40 synergize with cytokines (e.g., IL-4 and IL-5) to drive B cell activation. However, primary T cells preactivated via CD3 alone cannot induce B cell proliferation; we have shown previously that costimulation of T cells via CD3 and CD28 stabilizes the expression of the CD40L, which we propose contributes to their capacity to act as competent helper-effector cells. Here we show that an additional, critical reason why CD3-stimulated CD40L-bearing T cells are incompetent helper cells is because they secrete insufficient IL-2. In contrast, CD28/CD3-activated T cells induce B cells to become IL-2 responsive via a combination of CD40L and IL-2-mediated signals, and these two stimuli subsequently drive B cell proliferation and IgM secretion. We therefore propose that T cells must first encounter Ag in conjunction with CD80/86 on APCs. This leads to the stable expression of CD40L and maximal secretion of IL-2, which together render primary T cells competent to activate B cells in an IL-2-dependent fashion.
This article has been cited by other articles:
![]() |
P. Tsimbouri, Y. Al-Sheikh, M. E. Drotar, W. Cushley, and J. B. Wilson Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival J. Gen. Virol., November 1, 2008; 89(11): 2821 - 2832. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Soeiro, A. Mohamedali, H. M. Romanska, N. C. Lea, E. S. Child, J. Glassford, S. J. Orr, C. Roberts, K. N. Naresh, E.-N. Lalani, et al. p27Kip1 and p130 Cooperate To Regulate Hematopoietic Cell Proliferation In Vivo. Mol. Cell. Biol., August 1, 2006; 26(16): 6170 - 6184. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bry, M. Brigl, and M. B. Brenner CD4+-T-Cell Effector Functions and Costimulatory Requirements Essential for Surviving Mucosal Infection with Citrobacter rodentium Infect. Immun., January 1, 2006; 74(1): 673 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Moir, K. M. Ogwaro, A. Malaspina, J. Vasquez, E. T. Donoghue, C. W. Hallahan, S. Liu, L. A. Ehler, M. A. Planta, S. Kottilil, et al. Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals PNAS, May 13, 2003; 100(10): 6057 - 6062. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Lee, L. Haynes, S. M. Eaton, S. L. Swain, and T. D. Randall The Biological Outcome of CD40 Signaling Is Dependent on the Duration of CD40 Ligand Expression: Reciprocal Regulation by Interleukin (IL)-4 and IL-12 J. Exp. Med., September 2, 2002; 196(5): 693 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Wingren, R. Hadzic, A. Forsgren, and K. Riesbeck The Novel IgD Binding Protein from Moraxella catarrhalis Induces Human B Lymphocyte Activation and Ig Secretion in the Presence of Th2 Cytokines J. Immunol., June 1, 2002; 168(11): 5582 - 5588. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Plitnick, R. A. Jordan, J. A. Banas, D. M. Jelley-Gibbs, M. C. Walsh, M. T. Preissler, and E. J. Gosselin Lipoteichoic Acid Inhibits Interleukin-2 (IL-2) Function by Direct Binding to IL-2 Clin. Vaccine Immunol., September 1, 2001; 8(5): 972 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Blair, J. L. Riley, D. M. Harlan, R. Abe, D. K. Tadaki, S. C. Hoffmann, L. White, T. Francomano, S. J. Perfetto, A. D. Kirk, et al. Cd40 Ligand (Cd154) Triggers a Short-Term Cd4+ T Cell Activation Response That Results in Secretion of Immunomodulatory Cytokines and Apoptosis J. Exp. Med., February 21, 2000; 191(4): 651 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W.-F. Lam, J. Glassford, L. Banerji, N. S. B. Thomas, P. Sicinski, and G. G. B. Klaus Cyclin D3 Compensates for Loss of Cyclin D2 in Mouse B-lymphocytes Activated via the Antigen Receptor and CD40 J. Biol. Chem., February 4, 2000; 275(5): 3479 - 3484. [Abstract] [Full Text] [PDF] |
||||
![]() |
H-A Kim, Y Heo, S-Y Oh, K-J Lee, and D A Lawrence Altered serum cytokine and immunoglobulin levels in the workers exposed to antimony Human and Experimental Toxicology, October 1, 1999; 18(10): 607 - 613. [Abstract] [PDF] |
||||
![]() |
J. Glassford, M. Holman, L. Banerji, E. Clayton, G. G. B. Klaus, M. Turner, and E. W.-F. Lam Vav Is Required for Cyclin D2 Induction and Proliferation of Mouse B Lymphocytes Activated via the Antigen Receptor J. Biol. Chem., October 26, 2001; 276(44): 41040 - 41048. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |